GLP-1 receptor agonist compounds having stabilized regions
US9217022B2 · kind B2 · utility
3Cited by
2References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 27, 2011 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Sep 8, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides GLP-1 receptor agonist compounds having stabilized regions corresponding to alpha-helical regions of the natural peptide compounds. The disclosure also provides benzamide-containing exendin-4 analogs and alkene-constrained exendin-4 analogs, both of which have stabilized regions corresponding to alpha-helical regions of exendin-4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.